Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Spark New Zealand (SPK) / HY26

TenPeaks transaction with Pacific Equity Partners (PEP) puts Spark New Zealand's debt headroom in focus

The NZ$453m initial cash proceeds and NZ$98m deferred cash proceeds from the TenPeaks transaction with Pacific Equity Partners (PEP) is relevant to debt headroom, while borrowings and gearing remain the direct evidence.

Telecommunications & Media / Telecommunications

SPK revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $1.9m, versus $3.7b in FY25.

SPK EBITDAI margin

EBITDAI margin across covered periods.

↗
Loading chart...
  • HY23 SPK: Unprecedented high ebitda margin. 41.1%; 4-period range 21.6% to 28.5%. EBITDA margin: 41.1%, unprecedented high; 4-period mean 25.1%, range 21.6%-28.5%.
  • FY23 SPK: Unprecedented high ebitda margin. 38.3%; 4-period range 28.3% to 31.3%. EBITDA margin: 38.3%, unprecedented high; 4-period mean 30.2%, range 28.3%-31.3%.
  • HY25 SPK: Outside range low ebitda margin. 21.6%; 4-period range 23.7% to 41.1%. EBITDA margin: 21.6%, below normal range; 4-period mean 30.0%, range 23.7%-41.1%.
  • FY25 SPK: Outside range low ebitda margin. 28.3%; 4-period range 30.1% to 38.3%. EBITDA margin: 28.3%, below normal range; 4-period mean 32.7%, range 30.1%-38.3%.
EBITDA margin: 28.3%, below normal range; 4-period mean 32.7%, range 30.1%-38.3%.

SPK operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was $0.6m, versus $680m in FY25.

SPK working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY23 SPK: Outside range high operating working-capital movement. $15m; 4-period range $-106.9m to $0m. Operating working-capital movement: NZ$15.0m, above normal range; 0/4 prior periods had builds, and 2 had releases averaging NZ$-53.9m.
  • FY24 SPK: Outside range low operating working-capital movement. $-490.5m; 4-period range $-479.5m to $504.5m. Operating working-capital movement: NZ$-490.5m, below normal range; 2/4 prior periods had builds averaging NZ$300.8m, and 2 had releases averaging NZ$-240.7m.
  • HY25 SPK: Unprecedented low operating working-capital movement. $-106.9m; 4-period range $-1m to $15m. Operating working-capital movement: NZ$-106.9m, unprecedented low; 1/4 prior periods had builds averaging NZ$15.0m, and 1 had releases averaging NZ$-1.0m.
  • FY25 SPK: Unprecedented high operating working-capital movement. $504.5m; 4-period range $-490.5m to $97m. Operating working-capital movement: NZ$504.5m, unprecedented high; 1/4 prior periods had builds averaging NZ$97.0m, and 3 had releases averaging NZ$-324.0m.
Operating working-capital movement: NZ$504.5m, unprecedented high; 1/4 prior periods had builds averaging NZ$97.0m, and 3 had releases averaging NZ$-324.0m.
Release date
18 February 2026
Published
21 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY26 vs HY25

Revenue

$1.9m

-2.4% ↓ vs $1.9m

Net profit after tax

$0.1m

↑ vs $0m

Net cash inflow from operating activities

$0.6m

+119.3% ↑ vs $0.28m

Interim dividend per share

8.0c

-36.0% ↓ vs 12.5c

Profit before tax

$0.1m

flat vs $0.1m

Cash and cash equivalents

$0.09m

-15.0% ↓ vs $0.1m

Total assets

$4.4m

-10.6% ↓ vs $4.9m

What changed

Revenue fell 2.4% to NZ$1,893m, while reported EBITDAI of NZ$448m delivered an EBITDAI margin of 23.7% — below Annolyse's historical baseline range of 26.8%–41.1% and 8.4 percentage points under the three-period mean of 32.1%

NPAT grew 82.9% to NZ$64m, but that lift came off a depressed HY25 base; PBT was effectively flat at 0.0% growth, and NPAT margin of 5.3% sits at the lower edge of the four-period range.

Two balance-sheet signals stand out against the company's own history: net debt/EBITDA of 3.1x is above the historical baseline range of 0.70x–2.81x, and the payout ratio versus NPAT of 235.3% is well above the three-period mean of 105.8%. Operating cash flow of NZ$603m drove cash conversion (OCF/EBITDA) to 134.6%, above the historical range of 35.4%–85.1%. The interim dividend was cut to 8.0 cents from 12.5 cents.

What matters

Earnings recovery is real but narrow

TenPeaks transaction with Pacific Equity Partners (PEP) adds balance-sheet context, with NZ$453m initial cash proceeds and NZ$98m deferred cash proceeds, but borrowings and gearing are the direct leverage evidence.

PBT growth of 0.0% is the cleaner read than the 82.9% NPAT jump, which is flattered by the HY25 base and a slightly lower effective tax rate (38.6% versus 40.7%). The 33.7pp gap between NPAT and PBT growth means the headline understates how thin the underlying profit improvement is. EBITDAI margin at 23.7%, well below the 32.1% historical mean, suggests the cost-out work has not yet restored normalised profitability.

Leverage is elevated against Spark's own history. Net debt/EBITDA at 3.1x exceeds the prior three-period range (0.70x–2.81x) by a full turn above the mean of 2.02x. Gross borrowings did fall 20.4% to NZ$1.5b, which is the deleveraging direction management has signalled, but the ratio remains stretched because the EBITDA denominator has compressed. This matters because it constrains capacity to absorb further earnings softness without further dividend or capex adjustment.

The dividend now exceeds earnings by a wide margin. A payout ratio of 235.3% against NPAT — more than double the three-period mean of 105.8% — is only sustainable if cash conversion remains elevated and the earnings base rebuilds. The 36% cut in declared interim DPS to 8.0 cents acknowledges this, but on current NPAT the dividend is still not covered.

Expectations

No stated targets are supplied for HY26 and no forward-work disclosure is available

Against HY25's share of FY25 (52.1% of revenue, just 13.5% of NPAT), the FY25 shape was heavily second-half-weighted on profit. Annualising HY26 revenue gives NZ$3.8b, modestly above FY25's NZ$3.7b, but the EBITDAI margin gap to historical norms means absolute earnings recovery depends on continued cost-out and mix improvement rather than top-line.

The gap that matters is between the company's own historical EBITDAI margin (mean 32.1%) and the current 23.7%. Until that re-rates, leverage and payout pressure will continue to be the binding constraints.

Quality of result

The cash result is genuinely strong: OCF of NZ$603m more than doubled, cash conversion at 134.6% is above Annolyse's historical range, and free cash flow of NZ$107m rose 39% with FCF/NPAT at 167.2%

Operating working-capital movement was a neutral NZ$0m — within the historical range — so the cash strength is not a working-capital release flattering the half. Inventory days edged up only 1.4 days to 12.0.

That said, the durability of the cash uplift is the open question. Capex rose 7.5% to NZ$271m (14.3% of revenue), and the EBITDAI margin remains structurally below historical norms. The PBT-versus-NPAT divergence and the tax rate moving from 40.7% to 38.6% mean the 82.9% NPAT growth overstates operating momentum. The cleaner read — flat PBT on declining revenue and a margin still 8.4pp below the historical mean — suggests the earnings base has not yet recovered enough to support either current leverage or current distribution policy on a normalised basis.

Unresolved

Open questions

What level of EBITDAI margin does management view as the normalised run-rate, and what is the path back to the historical 32%+ range?
How will the payout ratio be reconciled with reported earnings if NPAT does not recover materially in H2?
Why did the effective tax rate fall from 40.7% to 38.6%, and is that level sustainable into FY27?
What is the targeted net debt/EBITDA ratio, and over what timeframe does management expect to return inside the historical 0.7x–2.8x range?
How much of the H1 cash conversion uplift is repeatable versus timing-driven into H2?

This briefing cannot assess management's specific FY26 EBITDAI guidance range or competitive dynamics in mobile and broadband pricing that may drive H2 revenue trajectory.

Chat

Ask about SPK HY26

Ask follow-up questions about Spark New Zealand's HY26 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about SPK HY26

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Spark New Zealand's HY26 result.

What level of EBITDAI margin does management view as the normalised run-rate, and what is the path back to the historical 32%+ range?Why does "Earnings recovery is real but narrow" matter?How strong was the cash and earnings quality in HY26?What should I watch next for SPK after HY26?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Interim Financial Statements

HY26 / financial report↗

Investor Presentation

HY26 / results presentation↗

Market Release

HY26 / results release↗

Results Announcement

HY26 / results announcement↗

Prior comparable period

Interim Financial Statements

HY25 / financial report↗

Investor Presentation

HY25 / results presentation↗

Market Release

HY25 / results release↗

Results Announcement

HY25 / results announcement↗

Full-year context

1. Market Release

FY25 / results release↗

2. Results Announcement

FY25 / results announcement↗

4. Annual Report

FY25 / financial report↗

5. Investor Presentation

FY25 / results presentation↗

Release context

Market Release - Spark releases FY30 strategy and update on Chair succession

FY25 / commentary↗

Spark announces sale of 75% of data centre business

FY25 / commentary↗

Spark New Zealand Limited's Annual Meeting Results 2024

HY25 / commentary↗

Spark Notifies of S&P Outlook Update

HY25 / commentary↗

Market Release - Spark releases FY30 strategy and update on Chair succession

HY26 / commentary↗

Spark completes sale of 75% of data centre business to PEP

HY26 / commentary↗

Spark New Zealand Limited's Annual Meeting Results 2025

HY26 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Leverage and balance-sheet risk

Net debt / EBITDA is 3.10x for this result.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 33.7pp.

→

Dividend coverage and payout pressure

Dividend payout versus NPAT is 235.3%.

→

Cash conversion quality

This result converted 134.6% of EBITDA to operating cash flow.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when SPK publishes next

Get the next Spark New Zealand briefing and related NZX reporting-season updates by email.